Acute toxicity of an anti-Fas antibody in mice

Toxicologic Pathology

Volumn 27, Issue 4, 1999, Pages 412-420

  Kakinuma, Chihaya ^a   Takagaki, Kinya ^a   Yatomi, Takehiro ^a   Nakamura, Norio ^a   Nagata, Shigekazu ^b   Uemura, Akio ^a   Shibutani, Yasunori ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Acute toxicity; Anti Fas antibody; Apoptosis; Jo2; Mice; Pathology

Indexed keywords

FAS ANTIBODY; FAS ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; FEMALE; HAMSTER; HISTOPATHOLOGY; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CRICETINAE;

EID: 0032802737     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339902700404     Document Type: Article

References (19)

1. Connors S, Rankin DR, Gandolfi AJ, Krumdieck CL, Koep LJ, and Brendel K (1990). Cocaine hepatotoxicity in cultured liver slices: A species comparison. Toxicology 61: 171-183.
2. Ellis RE, Yuan J, and Horviz HR (1991). Mechanisms and functions of cell death. Ann. Rev. Cell Biol. 7: 663-698.
3. Kraal G (1992). Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132: 31-74.
4. Krajewska M, Wang H-G, Krawjeski S, Zapata JM, Shabaik A, Gascoyne R, and Reed JC (1997). Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 57:1605-1613.
5. Lacronique V, Mignon A, Fabre M, Violet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Joulin V, and Kahn A (1996). Bcl-2 protects from lethal hepatic apoptosis induced by anti-Fas antibody in mice. Nat. Med. 2: 80-86.
6. Lowin B, Hahne M, Mattann C, and Tschopp J (1994). Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 374: 650-652.
7. Lücking-Famira KM, Daniel PT, Möller P, Krammer PH, and Debatin KM (1994). APO-1(CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. Leukemia 8: 1825-1833.
8. Möller P, Walczak H, Riedl S, Sträter J, and Krammer PH (1996). Paneth cells express high levels of CD95 ligand transcripts. Am. J. Pathol. 149: 9-13.
9. Nishimura Y, Hirabayashi Y, Matsuzaki Y, Musette P, Ishii A, Nakauchi H, Inoue T, and Yonehara S (1997). In vivo analysis of Fas antigen-mediated apoptosis: Effects of agonistic anti-mouse mAb on thymus, spleen and liver. Int. Immunol. 9: 307-316.
10. Ogasawara J, Watanabe FR, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, and Nagata S (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809.
11. Popp JA and Cattley RC (1991). Hepatobiliary system. In: Handbook of Toxicologic Pathology, WM Haschek and CG Rousseaux (eds). Academic Press, San Diego, pp. 279-314.
12. Raff MC (1992). Social controls on cell survival and cell death. Nature 356: 397-400.
13. Redondo C, Flores I, Gonzalez A, Nagata S, Carrera AC, Merida I, and Martinez AC (1996). Linomide prevents the lethal effect of anti-Fas antibody and reduces Fas-mediated ceramide production in mouse hepatocytes. J. Clin. Invest. 98: 1245-1252.
14. Rodriguez BI, Matsuura K, Khatib K, Reed JC, Nagata S, and Vassalli P (1996). A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183: 1031-1036.
15. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, and Nagata S (1995). Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154: 3806-3813.
16. Suda T, Takahashi T, Golstein P, and Nagata S (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178.
17. Tartaglia LA, Ayres TM, Wong GHW, and Goeddl DV (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853.
18. Wyllie AH, Kerr JFR, and Currie AR (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
19. Yonehara S, Ishii A, and Yonehara M (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756.